161 related articles for article (PubMed ID: 33419817)
1. 20(S)-Ginsenoside Rh2 Suppresses Oral Cancer Cell Growth by Inhibiting the Src-Raf-ERK Signaling Pathway.
Zhang H; Yi J; Kim E; Choo Y; Hai H; Kim K; Kim EK; Ryoo Z; Kim M
Anticancer Res; 2021 Jan; 41(1):227-235. PubMed ID: 33419817
[TBL] [Abstract][Full Text] [Related]
2. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
[TBL] [Abstract][Full Text] [Related]
4. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells.
Shi X; Yang J; Wei G
Mol Med Rep; 2018 Mar; 17(3):4811-4816. PubMed ID: 29363731
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Cheng CC; Yang SM; Huang CY; Chen JC; Chang WM; Hsu SL
Cancer Chemother Pharmacol; 2005 Jun; 55(6):531-40. PubMed ID: 15739095
[TBL] [Abstract][Full Text] [Related]
9. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.
Liu GW; Liu YH; Jiang GS; Ren WD
Hum Cell; 2018 Jul; 31(3):189-198. PubMed ID: 29582366
[TBL] [Abstract][Full Text] [Related]
10. [Ginsenoside Rh2 inhibits proliferation and promotes apoptosis of leukemia KG1-α cells].
You Z; Chen D; Wei Q; Zhao L; Xia J; Li D; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):565-8. PubMed ID: 24909273
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer Effect of 20(S)-Ginsenoside-Rh2 on Oral Squamous Cell Carcinoma Cells
Zhang BP; Li B; Cheng JY; Cao R; Gao ST; Huang CJ; Li RP; Ning J; Liu B; Li ZG
Biomed Environ Sci; 2020 Sep; 33(9):713-717. PubMed ID: 33106217
[No Abstract] [Full Text] [Related]
13. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
14. Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway.
Huang YW; Chuang CY; Hsieh YS; Chen PN; Yang SF; Shih-Hsuan-Lin ; Chen YY; Lin CW; Chang YC
Environ Toxicol; 2017 Mar; 32(3):1037-1046. PubMed ID: 27322511
[TBL] [Abstract][Full Text] [Related]
15. Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells.
Kim JH; Choi JS
Physiol Res; 2016 Dec; 65(6):1031-1037. PubMed ID: 27959575
[TBL] [Abstract][Full Text] [Related]
16. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Chen Y; Liu ZH; Xia J; Li XP; Li KQ; Xiong W; Li J; Chen DL
Oncol Rep; 2016 Jul; 36(1):137-46. PubMed ID: 27121661
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling.
Yang X; Zheng YT; Rong W
Life Sci; 2019 Dec; 239():116916. PubMed ID: 31626792
[TBL] [Abstract][Full Text] [Related]
18. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
